About this trial

The goal of this observational study is to develop, implement, and evaluate a machine learning algorithm-based Hepatitis C Emergency Department (HepC-EnD) screening tool for use in emergency departments (EDs) to identify patients at high risk of hepatitis C virus (HCV) infection. HepC-EnD will be integrated into the University of Florida Health electronic health record (EHR) system as a best practice alert (BPA) pop-up for ED providers, notifying them of patients at high risk for HCV infection and recommending both HCV and human immunodeficiency virus (HIV) screening. Investigators aim to enhance the screening and diagnosis of individuals who may otherwise remain undiagnosed and untreated.

The implementation outcomes (e.g., usability) and effectiveness outcomes (e.g., HCV screening and diagnosis rates) of HepC-EnD targeted screening will be compared with universal screening (FOCUS) and conventional physician-initiated screening programs in EDs.

Eligibility criteria

Qualifiers

18-79 years of age

Disqualifiers

< 18 years of age

Medically unstable

Trial design

Treatments tested in this trial

  • Physician-Initiated Screening (Conventional Screening)
  • FOCUS (Universal Screening)
  • HepC-EnD (Targeted Screening)

Treatment groups

6,466 Participants
are divided into 3 treatment groups

Locations

3
UF Health Shands Emergency Room / Trauma Center32608, GainesvilleFlorida, United States
UF Health Jacksonville Emergency Room32209, JacksonvilleFlorida, United States
UF Health North Emergency Room32218, JacksonvilleFlorida, United States

Sponsors and collaborators

University of Florida

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator